QuidelOrtho Corp (QDEL)
44.19
-0.01
(-0.02%)
USD |
NASDAQ |
May 31, 16:00
44.20
+0.01
(+0.02%)
After-Hours: 20:00
QuidelOrtho Cash from Financing (Quarterly): -18.50M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -18.50M |
December 31, 2023 | -57.80M |
September 30, 2023 | -48.70M |
June 30, 2023 | -99.70M |
March 31, 2023 | -59.60M |
December 31, 2022 | -31.70M |
September 30, 2022 | -126.00M |
June 30, 2022 | 413.10M |
March 31, 2022 | -3.40M |
December 31, 2021 | -0.90M |
September 30, 2021 | 1.80M |
June 30, 2021 | -144.35M |
March 31, 2021 | -29.65M |
December 31, 2020 | -0.057M |
September 30, 2020 | -43.20M |
June 30, 2020 | -87.72M |
March 31, 2020 | 0.705M |
December 31, 2019 | -15.50M |
September 30, 2019 | -5.957M |
June 30, 2019 | -62.15M |
March 31, 2019 | -14.68M |
December 31, 2018 | -29.58M |
September 30, 2018 | 2.476M |
June 30, 2018 | -105.15M |
March 31, 2018 | -111.80M |
Date | Value |
---|---|
December 31, 2017 | 256.47M |
September 30, 2017 | 9.89M |
June 30, 2017 | 2.126M |
March 31, 2017 | 2.121M |
December 31, 2016 | 3.575M |
September 30, 2016 | 2.546M |
June 30, 2016 | 0.40M |
March 31, 2016 | -23.32M |
December 31, 2015 | -2.692M |
September 30, 2015 | -14.51M |
June 30, 2015 | -11.70M |
March 31, 2015 | -0.356M |
December 31, 2014 | 167.95M |
September 30, 2014 | 1.006M |
June 30, 2014 | 0.429M |
March 31, 2014 | -1.326M |
December 31, 2013 | 0.856M |
September 30, 2013 | 1.117M |
June 30, 2013 | 1.001M |
March 31, 2013 | -1.184M |
December 31, 2012 | -11.28M |
September 30, 2012 | 1.373M |
June 30, 2012 | 0.008M |
March 31, 2012 | -27.61M |
December 31, 2011 | 0.656M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-144.35M
Minimum
Jun 2021
413.10M
Maximum
Jun 2022
-20.96M
Average
-30.67M
Median
Cash from Financing (Quarterly) Benchmarks
Boston Scientific Corp | 1.569B |
Perspective Therapeutics Inc | 166.33M |
Xtant Medical Holdings Inc | 5.179M |
Asensus Surgical Inc | 0.811M |
Catheter Precision Inc | -0.11M |
Cash from Financing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -0.70M |
Cash from Investing (Quarterly) | -20.20M |
Free Cash Flow | -118.80M |
Free Cash Flow Per Share (Quarterly) | -0.9985 |
Free Cash Flow to Equity (Quarterly) | -54.30M |
Free Cash Flow to Firm (Quarterly) | -22.99M |
Free Cash Flow Yield | -4.02% |